0,838  0,006  Caspase 9 stimulant
0,810  0,003  Antimutagenic
0,808  0,005  GST A substrate
0,722  0,007  Sensitization
0,714  0,004  Superoxide dismutase inhibitor
0,702  0,014  TNF expression inhibitor
0,680  0,008  CTGF expression inhibitor
0,666  0,005  Ulceration
0,666  0,025  Antineoplastic (breast cancer)
0,646  0,013  Chemoprotective
0,638  0,007  Antipyretic
0,637  0,012  Vasodilator, peripheral
0,629  0,008  Antipruritic, allergic
0,622  0,016  Cholesterol antagonist
0,610  0,005  Antihypoxic
0,612  0,016  Antihypercholesterolemic
0,632  0,043  Apoptosis agonist
0,609  0,020  CYP2C9 substrate
0,589  0,020  Aldehyde oxidase inhibitor
0,570  0,003  Succinate dehydrogenase inhibitor
0,572  0,009  Amyloid beta aggregation inhibitor
0,575  0,013  Antioxidant
0,564  0,003  GST P1-1 substrate
0,570  0,010  Free radical scavenger
0,591  0,032  Transcription factor NF kappa B inhibitor
0,561  0,017  Radioprotector
0,558  0,015  Histamine release inhibitor
0,538  0,004  VCAM1 expression inhibitor
0,531  0,006  UGT1A3 substrate
0,516  0,004  Cystathionine beta-synthase inhibitor
0,522  0,016  FMO1 substrate
0,515  0,009  UGT1A1 substrate
0,513  0,010  Antihypertriglyceridemic
0,512  0,009  UGT2B4 substrate
0,515  0,018  Chemopreventive
0,502  0,005  NOS3 expression enhancer
0,515  0,019  AR expression inhibitor
0,518  0,022  CYP1A2 substrate
0,513  0,017  NOS2 expression inhibitor
0,508  0,018  Lipoxygenase inhibitor
0,519  0,036  Antileukemic
0,499  0,020  Apoptosis antagonist
0,496  0,025  CYP2C19 inhibitor
0,472  0,008  Melanin inhibitor
0,467  0,010  Anesthetic general
0,486  0,029  CYP2C19 substrate
0,469  0,018  Hypoglycemic
0,470  0,021  Proliferative diseases treatment
0,478  0,032  Antithrombotic
0,453  0,009  Monophenol monooxygenase inhibitor
0,468  0,026  Antineoplastic (cervical cancer)
0,444  0,004  Prostaglandin EP2 antagonist
0,485  0,047  Antineoplastic (lung cancer)
0,443  0,007  Amylase inhibitor
0,462  0,032  CYP2D6 substrate
0,435  0,009  Platelet adhesion inhibitor
0,443  0,018  UGT1A6 substrate
0,453  0,029  Caspase 3 stimulant
0,444  0,027  UGT1A9 substrate
0,442  0,025  Vasodilator, coronary
0,421  0,008  Antipruritic, non-allergic
0,450  0,037  Antiallergic
0,451  0,041  Prostate cancer treatment
0,498  0,088  Antiinflammatory
0,429  0,027  Antineoplastic (non-small cell lung cancer)
0,419  0,018  Calcium channel activator
0,438  0,039  Bone diseases treatment
0,428  0,030  ICAM1 expression inhibitor
0,421  0,023  Platelet antagonist
0,405  0,007  Sulfotransferase substrate
0,459  0,064  Cyclophilin D inhibitor
0,459  0,064  Antidiabetic
0,401  0,006  Insulin sensitizer
0,424  0,033  Lipoprotein disorders treatment
0,396  0,005  GABA C receptor agonist
0,402  0,011  GST M1-1 substrate
0,405  0,015  Abortion inducer
0,389  0,004  Carbonic anhydrase VI inhibitor
0,404  0,019  Pyruvate kinase inhibitor
0,418  0,033  Antiosteoporotic
0,439  0,057  5 Hydroxytryptamine release inhibitor
0,380  0,004  Carbonic anhydrase III inhibitor
0,402  0,028  Antiamyloidogenic
0,384  0,010  Tyrosine 3 hydroxylase inhibitor
0,390  0,017  Skin irritative effect
0,398  0,030  Antiprotozoal (Leishmania)
0,370  0,007  Carcinogenic, group 2B
0,384  0,022  Antineoplastic (lymphocytic leukemia)
0,400  0,038  NOS3 expression inhibitor
0,384  0,022  Antiulcerative
0,364  0,003  Keratolytic
0,364  0,004  Phobic disorders treatment
0,403  0,044  Antineoplastic (ovarian cancer)
0,390  0,031  DNA damaging
0,363  0,004  Histidine decarboxylase inhibitor
0,390  0,033  CYP1A2 inhibitor
0,357  0,004  Choleretic
0,369  0,016  Antiseptic
0,365  0,015  Skin whitener
0,372  0,025  Peroxidase inhibitor
0,352  0,006  Interleukin 1b antagonist
0,347  0,005  Carbonic anhydrase XIII inhibitor
0,348  0,007  Cholesterol synthesis inhibitor
0,361  0,022  Eye irritation, high
0,380  0,043  Cardioprotectant
0,369  0,033  Antineoplastic (lymphoma)
0,364  0,031  Antineoplastic (osteosarcoma)
0,381  0,050  Hepatic disorders treatment
0,363  0,032  Antidiabetic symptomatic
0,343  0,012  Alpha-N-acetylglucosaminidase inhibitor
0,345  0,015  Pneumotoxic
0,363  0,034  Mutagenic
0,335  0,009  Interleukin 1 antagonist
0,343  0,019  UGT2B7 substrate
0,342  0,021  Non-steroidal antiinflammatory agent
0,331  0,012  Antidote
0,332  0,013  Protein kinase stimulant
0,356  0,039  Radiosensitizer
0,346  0,032  Nitric oxide antagonist
0,320  0,007  Expectorant
0,344  0,031  Sigma receptor agonist
0,330  0,018  DNA methyltransferase I inhibitor
0,360  0,049  Antineoplastic (brain cancer)
0,360  0,050  Teratogen
0,362  0,053  Antipsoriatic
0,323  0,015  Protein-tyrosine phosphatase inhibitor
0,321  0,014  Antihelmintic (Nematodes)
0,343  0,037  Insulysin inhibitor
0,322  0,016  Phospholipase C inhibitor
0,341  0,036  Transcription factor STAT3 inhibitor
0,341  0,040  FMO3 substrate
0,329  0,030  UDP-glucuronosyltransferase substrate
0,338  0,039  Carcinogenic
0,339  0,041  Cardiovascular analeptic
0,350  0,057  5 Hydroxytryptamine release stimulant
0,318  0,026  P-glycoprotein inhibitor
0,365  0,073  CYP3A4 substrate
0,332  0,040  Hypolipemic
0,325  0,034  5 Hydroxytryptamine uptake stimulant
0,333  0,041  Interleukin antagonist
0,315  0,024  DNA methylase inhibitor
0,294  0,005  ABCA1 expression enhancer
0,374  0,086  15-Lipoxygenase inhibitor
0,365  0,078  GABA C receptor rho-3 antagonist
0,298  0,011  5-Lipoxygenase inhibitor
0,336  0,050  Hypoxia-inducible factor 1 alpha inhibitor
0,305  0,019  Tubulin antagonist
0,304  0,017  CYP2B6 inhibitor
0,285  0,004  Heat shock protein 70 antagonist
0,294  0,014  Phospholipase A2 inhibitor
0,320  0,042  Vascular (periferal) disease treatment
0,295  0,018  UGT2B15 substrate
0,316  0,043  Vasodilator
0,312  0,040  DNA synthesis inhibitor
0,287  0,015  Glutathione S-transferase substrate
0,283  0,011  Cell adhesion inhibitor
0,294  0,023  Antiacne
0,293  0,022  Carcinogenic, group 3
0,300  0,030  Hepatoprotectant
0,324  0,054  Embryotoxic
0,328  0,061  Antineoplastic (melanoma)
0,289  0,022  Interferon gamma antagonist
0,336  0,069  Antineoplastic (colorectal cancer)
0,291  0,027  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,323  0,059  Sodium/bile acid cotransporter inhibitor
0,307  0,044  Interleukin agonist
0,312  0,049  Tumour necrosis factor alpha release inhibitor
0,294  0,032  Antihypotensive
0,269  0,007  Catalase inhibitor
0,271  0,009  UGT2B10 substrate
0,311  0,050  Transcription factor STAT inhibitor
0,284  0,023  Restenosis treatment
0,267  0,009  Alcohol dehydrogenase substrate
0,270  0,014  Antifungal enhancer
0,271  0,015  UGT2B9 substrate
0,269  0,014  Carcinogenic, group 1
0,259  0,006  HIV-1 integrase (3'-Processing) inhibitor
0,291  0,040  Gastrin inhibitor
0,302  0,051  Antineoplastic (renal cancer)
0,264  0,016  LDLR expression enhancer
0,340  0,092  Immunosuppressant
0,313  0,065  Spasmolytic
0,261  0,013  Uterine stimulant
0,255  0,009  UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor
0,266  0,022  Liver fibrosis treatment
0,310  0,067  Antineoplastic (small cell lung cancer)
0,289  0,047  Antimitotic
0,332  0,092  CYP2C9 inhibitor
0,293  0,053  Myocardial infarction treatment
0,311  0,072  Antineoplastic (colon cancer)
0,244  0,005  Macrophage migration inhibitory factor inhibitor
0,255  0,016  Protein-tyrosine phosphatase 1B inhibitor
0,263  0,027  Tumour necrosis factor antagonist
0,289  0,053  Antiglaucomic
0,310  0,074  12-Lipoxygenase inhibitor
0,247  0,013  Mannose-6-phosphate isomerase inhibitor
0,288  0,054  Angiogenesis stimulant
0,255  0,022  Genotoxic
0,242  0,009  Antirickettsial
0,236  0,005  Leukotriene antagonist
0,235  0,004  Prostaglandin EP3 antagonist
0,253  0,023  Corneal wound healing stimulator
0,256  0,026  Lipid peroxidase inhibitor
0,235  0,007  HIV-1 integrase (Strand Transfer) inhibitor
0,285  0,062  Antineoplastic (glioma)
0,227  0,005  Carbonic anhydrase V inhibitor
0,235  0,014  Xanthine oxidase inhibitor
0,227  0,007  NAD(P)H dehydrogenase (quinone) inhibitor
0,287  0,069  Antidiabetic (type 2)
0,250  0,032  Acaricide
0,331  0,113  Antibacterial
0,225  0,007  Vanilloid 1 agonist
0,228  0,011  Mediator release inhibitor
0,278  0,061  Antineoplastic (liver cancer)
0,255  0,040  UGT1A4 substrate
0,219  0,005  Glutathione S-transferase inhibitor
0,227  0,013  Arachidonic acid antagonist
0,287  0,074  Antineoplastic (multiple myeloma)
0,226  0,014  Microtubule formation inhibitor
0,232  0,021  Aldehyde dehydrogenase inhibitor
0,216  0,004  Ornithine decarboxylase inhibitor
0,221  0,012  Antispirochetal
0,293  0,085  Antineoplastic (endocrine cancer)
0,227  0,021  SULT1A3 substrate
0,226  0,021  ATPase inhibitor
0,241  0,036  Amyloid beta precursor protein antagonist
0,229  0,025  Cyclooxygenase 1 inhibitor
0,220  0,017  Excitatory amino acid transporter EAAC1 inhibitor
0,219  0,018  Ferrochelatase inhibitor
0,209  0,009  Cell adhesion molecule inhibitor
0,203  0,004  Antifungal (Pneumocystis)
0,209  0,010  HIV-1 integrase (Overall Integration) inhibitor
0,216  0,017  Toll-Like receptor 2 antagonist
0,262  0,064  Cardiodepressant
0,209  0,012  Calcium antagonist
0,213  0,018  Antieczematic
0,200  0,005  Carbonic anhydrase VA inhibitor
0,218  0,026  Antiprotozoal (Coccidial)
0,214  0,024  Antihyperlipoproteinemic
0,218  0,028  Neurotensin receptor agonist
0,202  0,013  Mucolytic
0,297  0,108  Stroke treatment
0,213  0,024  DNA polymerase I inhibitor
0,202  0,015  UGT2B1 substrate
0,252  0,066  Cytostatic
0,261  0,075  Flavin-containing monooxygenase substrate
0,214  0,029  Insulin secretagoues
0,199  0,014  Breast cancer-resistant protein inhibitor
0,203  0,018  SULT1A1 substrate
0,191  0,008  Toll-Like receptor 4 antagonist
0,232  0,050  Neurotrophic factor enhancer
0,217  0,035  VEGF expression inhibitor
0,195  0,014  Estrogen antagonist
0,238  0,058  Platelet aggregation inhibitor
0,187  0,008  Prostaglandin antagonist
0,228  0,050  Nitric-oxide synthase stimulant
0,214  0,037  MAO inhibitor
0,192  0,014  Aldehyde dehydrogenase substrate
0,269  0,092  Respiratory analeptic
0,183  0,006  Carbonic anhydrase VB inhibitor
0,193  0,017  Adenylate cyclase stimulant
0,189  0,013  TRPA1 agonist
0,180  0,004  Leukotriene B4 antagonist
0,200  0,024  Chelator
0,212  0,037  Cyclooxygenase inhibitor
0,261  0,087  Antineoplastic (pancreatic cancer)
0,227  0,054  Antihelmintic
0,250  0,078  Antineoplastic (bladder cancer)
0,238  0,066  Antiparasitic
0,178  0,008  Peroxisome proliferator-activated receptor gamma agonist
0,238  0,068  Neuropeptide Y2 antagonist
0,191  0,022  Cyclooxygenase 3 inhibitor
0,232  0,065  Peptidyltransferase inhibitor
0,264  0,098  Analeptic
0,199  0,033  Aldose reductase substrate
0,203  0,039  CNS active muscle relaxant
0,168  0,004  Aconitate hydratase inhibitor
0,185  0,021  Carbonic anhydrase XV inhibitor
0,204  0,041  Antineoplastic (squamous cell carcinoma)
0,188  0,026  Cathepsin H inhibitor
0,175  0,014  Actinic keratosis treatment
0,170  0,009  UGT2B11 substrate
0,166  0,005  GABA aminotransferase inhibitor
0,167  0,009  Alcohol oxidase inhibitor
0,169  0,010  Glutamate decarboxylase inhibitor
0,164  0,006  Xanthine dehydrogenase inhibitor
0,226  0,068  Antiviral (West Nile virus)
0,228  0,070  Antineoplastic (glioblastoma multiforme)
0,198  0,043  Antiviral (Hepatitis C)
0,160  0,005  Transcription factor AP-1 inhibitor
0,181  0,026  Antiprotozoal (Amoeba)
0,210  0,056  Dual specificity phosphatase 3 inhibitor
0,255  0,101  Antiischemic
0,258  0,104  Antifungal
0,168  0,014  Ca2+-transporting ATPase inhibitor
0,170  0,019  Dementia treatment
0,166  0,015  Phosphofructokinase-1 inhibitor
0,161  0,010  Aldose reductase inhibitor
0,158  0,007  NMDA receptor agonist
0,158  0,008  Prostaglandin E2 antagonist
0,153  0,005  Carbonic anhydrase XIV inhibitor
0,204  0,056  Antiviral (Hepatitis)
0,225  0,077  Cyclic AMP phosphodiesterase inhibitor
0,164  0,016  Triose-phosphate isomerase inhibitor
0,185  0,038  GABA C receptor rho-2 antagonist
0,218  0,071  Cytotoxic
0,178  0,032  Gout treatment
0,164  0,019  Vascular dementia treatment
0,163  0,017  Prolactin inhibitor
0,189  0,044  Anesthetic
0,152  0,007  Hyperparathyroidism treatment
0,162  0,018  Porphobilinogen synthase inhibitor
0,150  0,007  3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor
0,149  0,006  Peroxisome proliferator-activated receptor alpha agonist
0,190  0,048  Antineoplastic (carcinoma)
0,190  0,048  Hair growth stimulant
0,172  0,031  MAO B inhibitor
0,296  0,155  Antiarthritic
0,155  0,015  Thioredoxin inhibitor
0,148  0,009  HIV-1 integrase inhibitor
0,160  0,022  Caspase 3 inhibitor
0,167  0,028  Coagulant
0,232  0,094  5 Hydroxytryptamine 1E antagonist
0,162  0,024  Sphingosine 1-phosphate receptor 4 antagonist
0,159  0,021  Beta glucuronidase inhibitor
0,181  0,043  Cytokine production inhibitor
0,297  0,160  Calcium channel L-type activator
0,139  0,003  Retinoid X alpha receptor agonist
0,151  0,017  GST T1-1 substrate
0,160  0,026  Photosensitizer
0,157  0,024  AMP-activated protein kinase stimulant
0,150  0,017  NADH dehydrogenase inhibitor
0,174  0,042  Antianemic
0,151  0,020  DOPA decarboxylase inhibitor
0,157  0,026  Antiviral (Papilloma)
0,155  0,024  Adenylate kinase inhibitor
0,137  0,008  Granulocyte macrophage colony stimulating factor agonist
0,151  0,023  Uric acid excretion stimulant
0,159  0,030  Gastritis treatment
0,144  0,017  Glutamate dehydrogenase inhibitor
0,140  0,013  Beta tubulin antagonist
0,129  0,003  Retinoid X receptor agonist
0,134  0,008  Anticholelithogenic
0,154  0,028  DNA repair enzyme inhibitor
0,290  0,165  Alpha-glucosidase inhibitor
0,150  0,027  Gastric antisecretory
0,186  0,063  Dual specificity phosphatase inhibitor
0,127  0,004  Prostaglandin agonist
0,158  0,036  Growth stimulant
0,152  0,032  Contraceptive female
0,126  0,007  NMDA receptor glycine site agonist
0,136  0,019  Antidote, mercury
0,131  0,015  Phenylalanine 4-hydroxylase inhibitor
0,158  0,043  Alkylator
0,119  0,005  Exportin-1 inhibitor
0,162  0,047  M18 aspartyl aminopeptidase inhibitor
0,156  0,041  Antibacterial (Helicobacter pylori)
0,118  0,004  Glucose-6-phosphate translocase inhibitor
0,208  0,095  Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor
0,199  0,086  Antineoplastic enhancer
0,248  0,135  Thioredoxin glutathione reductase inhibitor
0,132  0,020  Antiviral (Rhinovirus)
0,175  0,064  Aldehyde oxidase substrate
0,127  0,018  Glutamate release inhibitor
0,136  0,027  Carcinogenic, group 2A
0,116  0,009  Endocannabinoid uptake inhibitor
0,110  0,003  Retinoid X beta receptor agonist
0,108  0,003  Kainate receptor agonist
0,189  0,083  Septic shock treatment
0,111  0,006  Glutamate (mGluR7) antagonist
0,155  0,050  Cyclooxygenase 2 inhibitor
0,108  0,003  Retinoid X gamma receptor agonist
0,112  0,008  Plasminogen activator inhibitor antagonist
0,237  0,134  Interleukin 2 agonist
0,163  0,059  Raynaud's phenomenon treatment
0,105  0,004  Retinoic acid alpha receptor agonist
0,132  0,031  GABA C receptor rho-1 antagonist
0,115  0,015  Biliverdin reductase inhibitor
0,111  0,011  Peroxisome proliferator-activated receptor gamma antagonist
0,131  0,033  Acetylcholine release stimulant
0,131  0,034  Sphingomyelinase inhibitor
0,112  0,014  Estrogen-related receptor beta agonist
0,146  0,048  Adenylate cyclase inhibitor
0,116  0,018  Leukotriene synthesis inhibitor
0,101  0,004  Prostaglandin EP4 antagonist
0,171  0,075  Muscle relaxant
0,120  0,024  Phosphodiesterase 6D inhibitor
0,114  0,019  Thioredoxin reductase inhibitor
0,191  0,097  Age-related macular degeneration treatment
0,113  0,019  Sphingosine 1-phosphate receptor 4 agonist
0,103  0,011  Antiviral (Parainfluenza)
0,108  0,017  Glycine receptor agonist
0,113  0,021  Estrogen receptor alpha antagonist
0,168  0,076  3C-like protease (Human coronavirus) inhibitor
0,266  0,175  Transcription factor inhibitor
0,097  0,007  Thromboxane synthase inhibitor
0,114  0,024  ATPase (Vacuolar H+) inhibitor
0,120  0,031  Antifungal (Aspergillus)
0,102  0,015  GABA B receptor agonist
0,091  0,004  Retinoic acid receptor agonist
0,195  0,108  RNA-directed DNA polymerase inhibitor
0,101  0,015  Antitreponemal
0,122  0,037  Anabolic
0,149  0,064  Sphingosine 1-phosphate receptor 5 antagonist
0,091  0,006  Glucose-6-phosphate isomerase inhibitor
0,090  0,006  Fumarate hydratase inhibitor
0,090  0,006  Peroxisome proliferator-activated receptor delta agonist
0,163  0,079  Catenin beta inhibitor
0,088  0,004  Prostaglandin E2 agonist
0,106  0,023  D-Ala-D-Ala ligase inhibitor
0,119  0,035  Alcohol dehydrogenase inhibitor
0,143  0,059  Cocaine dependence treatment
0,113  0,030  Antifungal (Candida)
0,202  0,119  Immunostimulant
0,094  0,012  SULT2A1 substrate
0,111  0,029  Bile acid receptor antagonist
0,086  0,005  Heparanase inhibitor
0,085  0,004  Leukotriene B4 receptor 1 antagonist
0,126  0,045  Antihelmintic (Fasciola)
0,264  0,184  DNA polymerase beta inhibitor
0,120  0,041  Creatine kinase inhibitor
0,096  0,018  Purinergic P2X1 antagonist
0,082  0,004  GABA transporter 3 inhibitor
0,129  0,051  Antiviral (Influenza B)
0,084  0,007  Ryanodine receptor antagonist
0,126  0,049  MAO A inhibitor
0,152  0,076  Hexokinase inhibitor
0,107  0,031  Cathepsin G inhibitor
0,105  0,030  Metalloproteinase-9 inhibitor
0,118  0,042  Potassium channel (Ca-activated) activator
0,083  0,008  Lysophosphatidic acid 3 receptor antagonist
0,148  0,074  Antidiarrheal
0,145  0,070  Cell wall synthesis inhibitor
0,078  0,003  Retinoid X receptor antagonist
0,141  0,067  Alkaline phosphatase inhibitor
0,081  0,007  Leukotriene C antagonist
0,081  0,007  Factor III inhibitor
0,153  0,080  Thrombolytic
0,092  0,019  CDC25B inhibitor
0,108  0,035  Metalloproteinase-2 inhibitor
0,100  0,027  CDC25A inhibitor
0,122  0,049  HDL-cholesterol increasing
0,092  0,019  Postmenopausal disorders treatment
0,122  0,050  GABA C receptor antagonist
0,080  0,008  Adenylate cyclase 1 inhibitor
0,258  0,186  DNA directed DNA polymerase inhibitor
0,179  0,108  5 Hydroxytryptamine 3E antagonist
0,143  0,071  Skeletal muscle relaxant
0,117  0,045  UDP-glucose 4-epimerase inhibitor
0,075  0,003  Retinoic acid alpha receptor antagonist
0,138  0,068  Farnesoid X receptor antagonist
0,083  0,012  Carbonic anhydrase VII inhibitor
0,084  0,014  Transcription factor RelA inhibitor
0,129  0,059  Beta amyloid protein antagonist
0,086  0,017  Thromboxane antagonist
0,093  0,023  Antidote, organophosphates
0,074  0,004  LFA antagonist
0,130  0,061  Papain-like protease (SARS coronavirus) inhibitor
0,087  0,018  Glutamate (mGluR6) antagonist
0,100  0,033  Vanilloid agonist
0,088  0,022  Protease 3C (Human rhinovirus) inhibitor
0,090  0,024  Carbamoyl phosphate synthetase inhibitor
0,081  0,014  Heme oxygenase stimulant
0,075  0,009  Pregnane X receptor antagonist
0,099  0,033  Na+ K+ transporting ATPase inhibitor
0,069  0,003  Retinoic acid receptor antagonist
0,078  0,013  Glutamate (mGluR group III) agonist
0,175  0,110  Antiparkinsonian, rigidity relieving
0,079  0,015  Thromboxane A2 antagonist
0,070  0,007  Prostacyclin antagonist
0,065  0,003  Retinoid X alpha receptor antagonist
0,066  0,005  Glutamate (mGluR8) agonist
0,107  0,047  Glutamate (mGluR7) agonist
0,064  0,004  Prostaglandin EP2 agonist
0,081  0,022  Antimycoplasmal
0,075  0,017  Postcoital contraceptive
0,101  0,043  Arylamine N-Acetyltransferase substrate
0,063  0,005  Sodium-dependent vitamin C transporter 2 inhibitor
0,075  0,018  Phosphorylase inhibitor
0,119  0,062  Interleukin 8 antagonist
0,077  0,021  Alpha tubulin antagonist
0,061  0,005  NMDA 2D receptor antagonist
0,107  0,052  Estrogen receptor beta antagonist
0,111  0,057  Aminopeptidase B inhibitor
0,063  0,009  Farnesoid X receptor agonist
0,100  0,048  Paget's disease treatment
0,061  0,009  RNA-directed RNA polymerase inhibitor
0,072  0,020  Glycine transporter 2 inhibitor
0,142  0,091  CF transmembrane conductance regulator agonist
0,137  0,086  Cytidine deaminase inhibitor
0,128  0,078  Bone formation stimulant
0,094  0,043  Myeloperoxidase inhibitor
0,148  0,097  Antipruritic
0,068  0,018  DNA helicase inhibitor
0,128  0,078  Sphingosine 1-phosphate receptor 2 antagonist
0,102  0,052  Lanosterol 14 alpha demethylase inhibitor
0,135  0,086  Antifungal (Cryptococcus)
0,053  0,004  Retinoic acid beta receptor agonist
0,059  0,010  GABA uptake inhibitor
0,060  0,011  Guanylate cyclase inhibitor
0,055  0,007  Leukotriene C4 antagonist
0,051  0,003  Retinoid X gamma receptor antagonist
0,117  0,069  Antineoplastic antimetabolite
0,051  0,004  ICAM 1 antagonist
0,065  0,018  Potassium channel Kv1.3 blocker
0,092  0,045  Inducible nitric-oxide synthase inhibitor
0,052  0,006  Integrin alpha1beta1 antagonist
0,102  0,055  Electrolyte absorption antagonist
0,052  0,006  Kynurenine 3 monooxygenase inhibitor
0,071  0,026  Acyl-CoA dehydrogenase inhibitor
0,072  0,028  Maillard reaction inhibitor
0,070  0,026  Estrogen agonist
0,048  0,004  Retinoic acid gamma receptor agonist
0,266  0,222  Antineoplastic (solid tumors)
0,128  0,085  Antiparkinsonian, tremor relieving
0,073  0,029  Prostaglandin F2 alpha antagonist
0,047  0,005  Prostaglandin EP4 agonist
0,165  0,124  Aryl hydrocarbon receptor agonist
0,122  0,081  Antihemorrhagic
0,068  0,027  Matrix metalloproteinase 1 inhibitor
0,079  0,038  Matrix metalloproteinase inhibitor
0,154  0,113  Psychostimulant
0,044  0,005  Leukotriene B4 receptor 2 antagonist
0,137  0,097  Pulmonary hypertension treatment
0,060  0,021  Squalene epoxidase inhibitor
0,095  0,056  SULT1E1 substrate
0,046  0,008  Methionyl aminopeptidase 2 inhibitor
0,047  0,009  Peroxisome proliferator-activated receptor alpha antagonist
0,052  0,014  Inosine monophosphate dehydrogenase inhibitor
0,170  0,132  ErbB-1 antagonist
0,080  0,042  Aminopeptidase I inhibitor
0,122  0,084  Antiprotozoal (Trichomonas)
0,052  0,015  Kainate receptor 2 antagonist
0,068  0,031  Argininosuccinate synthase inhibitor
0,051  0,014  3-Hydroxyanthranilate 3,4-dioxygenase inhibitor
0,203  0,167  Angiogenesis inhibitor
0,068  0,032  Calcium channel P-type blocker
0,058  0,023  CD45 antagonist
0,045  0,010  GABA transporter 2 inhibitor
0,039  0,003  Retinoid X beta receptor antagonist
0,047  0,011  Vanilloid 3 antagonist
0,136  0,100  Growth hormone agonist
0,088  0,054  Transcription factor NF kappa B stimulant
0,110  0,075  Anesthetic local
0,058  0,024  Anesthetic inhalation
0,074  0,040  Selectin antagonist
0,047  0,013  Cholesterol absorption inhibitor
0,039  0,006  Prostaglandin H2 antagonist
0,043  0,010  Prostaglandin D2 agonist
0,107  0,076  Myasthenia Gravis treatment
0,054  0,023  Estradiol 17 beta-dehydrogenase inhibitor
0,037  0,006  Inosine monophosphate dehydrogenase 2 inhibitor
0,063  0,033  Botulinum neurotoxin type A inhibitor
0,042  0,012  Leukotriene D4 antagonist
0,043  0,013  Free fatty acid receptor 1 antagonist
0,070  0,039  MDM2 inhibitor
0,158  0,128  Histone acetyltransferase inhibitor
0,034  0,004  GABA transporter inhibitor
0,049  0,019  Dihydrofolate reductase inhibitor
0,033  0,004  Integrin beta2 antagonist
0,117  0,088  Antihelmintic (Trematoda)
0,110  0,081  Transcription factor STAT6 inhibitor
0,137  0,108  Antianginal
0,042  0,013  Peroxisome proliferator-activated receptor delta antagonist
0,093  0,064  Antischistosomal
0,109  0,080  Shock treatment
0,138  0,110  Myocardial ischemia treatment
0,148  0,119  Antineoplastic (bone cancer)
0,036  0,007  Integrin beta5 antagonist
0,046  0,017  Diamine oxidase inhibitor
0,042  0,014  Carnitine palmitoyltransferase inhibitor
0,087  0,059  Interleukin 5 antagonist
0,042  0,014  Carnitine palmitoyltransferase 1 inhibitor
0,103  0,075  Electron transport complex I inhibitor
0,117  0,089  Interleukin 4 antagonist
0,042  0,015  VLA-4 antagonist
0,042  0,015  Glutamate (mGluR4) agonist
0,065  0,038  NMDA 2C receptor antagonist
0,128  0,101  Thiol protease inhibitor
0,064  0,038  Antidote, heavy metal
0,142  0,117  Lipocortins synthesis antagonist
0,065  0,040  Nitric oxide donor
0,077  0,052  Narcotic antagonist
0,034  0,009  Prostaglandin D2 antagonist
0,040  0,015  HMG CoA reductase inhibitor
0,032  0,008  Prostaglandin F2 alpha agonist
0,037  0,013  Glutamate (mGluR3) agonist
0,051  0,027  Integrin antagonist
0,042  0,019  Glutamate (mGluR3) antagonist
0,044  0,021  Membrane dipeptidase inhibitor
0,074  0,052  NAT1 substrate
0,026  0,004  Retinoic acid beta receptor antagonist
0,056  0,033  Alpha-mannosidase inhibitor
0,037  0,016  ATP citrate lysase inhibitor
0,036  0,015  Lysophosphatidic acid 2 receptor antagonist
0,037  0,016  Melatonin receptor 1A agonist
0,063  0,042  Caspase 9 inhibitor
0,127  0,107  Pregnane X receptor agonist
0,074  0,054  SULT1A2 substrate
0,068  0,049  Elastase 1 inhibitor
0,086  0,068  Antineoplastic, alkylator
0,036  0,018  HCV NS5B polymerase inhibitor
0,054  0,036  Sphingosine 1-phosphate receptor 5 agonist
0,022  0,004  Retinoic acid receptor gamma antagonist
0,087  0,070  Antiviral (Hepatitis A)
0,130  0,112  Mcl-1 antagonist
0,043  0,026  Kainate receptor antagonist
0,028  0,010  Prostaglandin EP1 antagonist
0,027  0,009  Monocarboxylic acid transporter inhibitor
0,027  0,009  Monocarboxylic acid transporter 1 inhibitor
0,023  0,006  Vesicular glutamate transport inhibitor
0,033  0,016  Uridine phosphorylase inhibitor
0,108  0,092  Acetylcholinesterase inhibitor
0,162  0,146  Antiviral (Ebola)
0,036  0,021  1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor
0,025  0,009  Lysophosphatidic acid 1 receptor antagonist
0,092  0,076  Urease inhibitor
0,069  0,054  Calcium channel L-type blocker
0,036  0,021  Histone deacetylase 5 inhibitor
0,070  0,056  Antibiotic
0,029  0,014  Thyroid hormone agonist
0,019  0,005  GABA transporter 1 inhibitor
0,019  0,005  Integrin alphaLbeta2 antagonist
0,054  0,042  Mannitol-1-phosphate 5-dehydrogenase inhibitor
0,034  0,021  Catechol O-methyltransferase inhibitor
0,028  0,016  Nicotinic acid receptor 2 antagonist
0,033  0,021  Estradiol 17 beta-dehydrogenase 3 inhibitor
0,062  0,050  Aryl hydrocarbon receptor antagonist
0,142  0,131  Antieczematic atopic
0,039  0,028  VCAM-1 antagonist
0,091  0,079  Antiviral (Poxvirus)
0,039  0,028  VCAM antagonist
0,019  0,009  Prostacyclin agonist
0,026  0,015  NMDA receptor glycine site antagonist
0,107  0,097  Retinoprotector
0,125  0,115  Neuropathy treatment
0,038  0,029  Dihydropteroate synthase inhibitor
0,114  0,105  Antiischemic, cerebral
0,023  0,014  Isoleucine-tRNA ligase inhibitor
0,040  0,031  Plasmepsin II inhibitor
0,015  0,006  Glutamate (mGluR6) agonist
0,092  0,083  Folate antagonist
0,049  0,040  Ornithine carbamoyltransferase inhibitor
0,268  0,259  Ca2+/calmodulin-dependent protein kinase kinase A inhibitor
0,017  0,009  Thromboxane A2 agonist
0,043  0,035  Mannosidase inhibitor
0,045  0,038  Carnitine palmitoyltransferase 1B inhibitor
0,035  0,027  Glutamate (mGluR8) antagonist
0,018  0,011  Free fatty acid receptor 1 agonist
0,042  0,035  Glutamate (mGluR group III) antagonist
0,164  0,157  Calpain inhibitor
0,085  0,080  Interleukin 1 beta converting enzyme inhibitor
0,017  0,012  G-protein-coupled receptor 120 agonist
0,030  0,025  Nucleoside transporters inhibitor
0,052  0,046  Dihydroorotate oxidase inhibitor
0,024  0,019  Lysophosphatidic acid receptor 1 agonist
0,167  0,162  Antituberculosic
0,033  0,028  Calcium-independent phospholipase A2 inhibitor
0,178  0,173  Prostaglandin dehydrogenase inhibitor
0,025  0,020  Urotensin II agonist
0,011  0,007  Thromboxane agonist
0,034  0,030  5-Alpha-reductase inhibitor
0,018  0,015  5-Alpha-reductase 2 inhibitor
0,061  0,058  Potassium channel large-conductance Ca-activated activator
0,086  0,083  Interleukin 12 antagonist
0,040  0,037  GABA B receptor antagonist
0,068  0,066  Phosphodiesterase VI inhibitor
0,018  0,016  Antibiotic Anthracycline-like
0,037  0,035  Liver X receptor alpha agonist
0,131  0,130  Wound healing agent
0,093  0,092  Multidrug resistance-associated protein 1 inhibitor
0,121  0,120  Acute respiratory distress syndrome (ARDS) treatment
0,020  0,020  CYP24 inhibitor

